|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.33 USD | -10.04% |
|
-0.21% | +15.92% |
| 04-15 | Top Premarket Decliners | MT |
| 01-30 | Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 | CI |
Universe Pharmaceuticals INC reported earnings results for the full year ended September 30, 2022. For the full year, the company reported sales was USD 40.14 million compared to USD 47.98 million a year ago. Net loss was USD 8.74 million compared to net income of USD 11.32 million a year ago.
Basic loss per share from continuing operations was USD 2.4 compared to basic earnings per share from continuing operations of USD 3.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.92% | 9.39M | |
| +41.06% | 6.26B | |
| -15.95% | 4.49B | |
| +6.36% | 3.29B | |
| -11.34% | 3.12B | |
| -3.12% | 2.5B | |
| +45.41% | 1.94B | |
| -7.74% | 1.68B | |
| -0.67% | 1.63B | |
| -11.32% | 1.56B |
UNIVERSE PHARMACEUTICALS INC 